110 related articles for article (PubMed ID: 33630128)
1. Intra- inter-observer repeatability in liver computed tomography volumetry in patients undergoing radioembolization simulation.
Masperi A; Cubadda V; Bombelli L; Labruna R; Bagnardi V; Fodor CI; Pagan E; Bonomo G; Orsi F
Abdom Radiol (NY); 2021 Jul; 46(7):3448-3455. PubMed ID: 33630128
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the parenchymal blood volume by C-arm computed tomography for radioembolization dosimetry.
Grözinger G; Kupferschläger J; Dittmann H; Maurer M; Grosse U; la Fougère C; Nikolaou K; Syha R; Ketelsen D
Eur J Radiol; 2016 Sep; 85(9):1525-31. PubMed ID: 27501884
[TBL] [Abstract][Full Text] [Related]
3. Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT).
Helmberger T; Golfieri R; Pech M; Pfammatter T; Arnold D; Cianni R; Maleux G; Munneke G; Pellerin O; Peynircioglu B; Sangro B; Schaefer N; de Jong N; Bilbao JI; ;
Cardiovasc Intervent Radiol; 2021 Jan; 44(1):21-35. PubMed ID: 32959085
[TBL] [Abstract][Full Text] [Related]
4. Radioembolization for the treatment of hepatocellular carcinoma.
Kim HC
Clin Mol Hepatol; 2017 Jun; 23(2):109-114. PubMed ID: 28494530
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Imaging Biomarkers for
Schobert I; Chapiro J; Nezami N; Hamm CA; Gebauer B; Lin M; Pollak J; Saperstein L; Schlachter T; Savic LJ
J Nucl Med; 2019 Aug; 60(8):1066-1072. PubMed ID: 30655331
[TBL] [Abstract][Full Text] [Related]
6. Yttrium-90 Radioembolization as a Salvage Treatment following Chemoembolization for Hepatocellular Carcinoma.
Johnson GE; Monsky WL; Valji K; Hippe DS; Padia SA
J Vasc Interv Radiol; 2016 Aug; 27(8):1123-9. PubMed ID: 27321889
[TBL] [Abstract][Full Text] [Related]
7. Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases.
Morsbach F; Pfammatter T; Reiner CS; Fischer MA; Sah BR; Winklhofer S; Klotz E; Frauenfelder T; Knuth A; Seifert B; Schaefer N; Alkadhi H
Invest Radiol; 2013 Nov; 48(11):787-94. PubMed ID: 23748229
[TBL] [Abstract][Full Text] [Related]
8.
Jreige M; Mitsakis P; Van Der Gucht A; Pomoni A; Silva-Monteiro M; Gnesin S; Boubaker A; Nicod-Lalonde M; Duran R; Prior JO; Denys A; Schaefer N
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1215-1222. PubMed ID: 28233086
[TBL] [Abstract][Full Text] [Related]
9. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of Yttrium-90 Radioembolization Dose Calculation Utilizing Intra-procedural Open Trajectory Cone Beam CT.
O'Connor PJ; Pasik SD; van der Bom IM; Bishay V; Radaelli A; Kim E
Cardiovasc Intervent Radiol; 2020 Feb; 43(2):295-301. PubMed ID: 31578635
[TBL] [Abstract][Full Text] [Related]
11. Expected and Unexpected Imaging Findings after
Spina JC; Hume I; Pelaez A; Peralta O; Quadrelli M; Garcia Monaco R
Radiographics; 2019; 39(2):578-595. PubMed ID: 30844345
[TBL] [Abstract][Full Text] [Related]
12. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
Egger ME; Armstrong E; Martin RC; Scoggins CR; Philips P; Shah M; Konda B; Dillhoff M; Pawlik TM; Cloyd JM
J Am Coll Surg; 2020 Apr; 230(4):363-370. PubMed ID: 32032719
[TBL] [Abstract][Full Text] [Related]
13. Analysis of failed therapy evaluations in radioembolization of primary and secondary liver cancers.
Masthoff M; Schindler P; Harders F; Heindel W; Wilms C; Schmidt HH; Pascher A; Stegger L; Rahbar K; Köhler M; Wildgruber M
J Cancer Res Clin Oncol; 2021 May; 147(5):1537-1545. PubMed ID: 33156407
[TBL] [Abstract][Full Text] [Related]
14. Histogram Analysis of CT Perfusion of Hepatocellular Carcinoma for Predicting Response to Transarterial Radioembolization: Value of Tumor Heterogeneity Assessment.
Reiner CS; Gordic S; Puippe G; Morsbach F; Wurnig M; Schaefer N; Veit-Haibach P; Pfammatter T; Alkadhi H
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):400-8. PubMed ID: 26216725
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
[TBL] [Abstract][Full Text] [Related]
16. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
Kallini JR; Gabr A; Salem R; Lewandowski RJ
Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Toxicity after Transarterial Radioembolization with Yttrium-90 Using Resin Microspheres for Neuroendocrine Tumor Liver Metastases.
Tomozawa Y; Jahangiri Y; Pathak P; Kolbeck KJ; Schenning RC; Kaufman JA; Farsad K
J Vasc Interv Radiol; 2018 Jun; 29(6):858-865. PubMed ID: 29724520
[TBL] [Abstract][Full Text] [Related]
18. Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis.
Gramenzi A; Golfieri R; Mosconi C; Cappelli A; Granito A; Cucchetti A; Marinelli S; Pettinato C; Erroi V; Fiumana S; Bolondi L; Bernardi M; Trevisani F;
Liver Int; 2015 Mar; 35(3):1036-47. PubMed ID: 24750853
[TBL] [Abstract][Full Text] [Related]
19. Comparing the performance of trained radiographers against experienced radiologists in the UK lung cancer screening (UKLS) trial.
Nair A; Gartland N; Barton B; Jones D; Clements L; Screaton NJ; Holemans JA; Duffy SW; Field JK; Baldwin DR; Hansell DM; Devaraj A
Br J Radiol; 2016 Oct; 89(1066):20160301. PubMed ID: 27461068
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of inter-observer variability according to RECIST 1.1 and its influence on response classification in CT measurement of liver metastases.
Bellomi M; De Piano F; Ancona E; Lodigiani AF; Curigliano G; Raimondi S; Preda L
Eur J Radiol; 2017 Oct; 95():96-101. PubMed ID: 28987705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
